Dr. Paulo Alberto Ramirez, MD

Dr. Ramirez practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Ramirez's NPI, 1790213882, was assigned on June 1, 2017. Dr. Ramirez holds California license A164412.

Dr. Ramirez's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Ramirez's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Ramirez is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramirez practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Ramirez's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Ramirez is licensed in California.

CMS data shows 788 Medicare services from Dr. Ramirez across 3 procedure codes in 2024, for 244 Medicare patients. Medicare paid $78,518 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 244 Medicare patients who saw Dr. Ramirez in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramirez's median patient age at 67, with 50% women.

In 2024, Dr. Ramirez wrote 291 Medicare Part D claims for 106 patients. 83% of them were for generic drugs. CMS names the drug for 53 of them, across 4 drugs with 11 or more claims each, at $612 in total drug cost. In 2022, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ramirez for performance year 2024, reported as part of a group. Dr. Ramirez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Ramirez from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $17.